Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 5, Issue 4, 2009, Pages 473-479

  Li, Xiao bo ^a   Zheng, Hao ^a   Zhang, Zhi ren ^b   Li, Miao ^a   Huang, Zhi yong ^a   Schluesener, Hermann J ^b   Li, Yuan yuan ^a   Xu, Shun qing ^a  

^a Institute of Environmental Medicine   (China)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aluminum oxide; Astrocytes; Microglia; Nanoparticles; Nanotoxicology

Indexed keywords

ACTIVATED ALUMINA; CHEMICAL ACTIVATION; IMMUNE SYSTEM; MAGNETIC LEVITATION VEHICLES; NANOPARTICLES; OXIDES; RATS;

ALUMINUM OXIDE NANOPARTICLES; ASTROCYTES; INNATE IMMUNE SYSTEMS; MICROGLIA; NANO-SIZED PARTICLES; NANOSCALED PARTICLES; NANOTOXICOLOGY; TOXICOLOGICAL EFFECTS;

ALUMINUM OXIDE;

ALUMINUM OXIDE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BRAIN; BRAIN CORTEX; CELL ACTIVATION; CONTROLLED STUDY; EXPOSURE; GLIA; HIPPOCAMPUS; INNATE IMMUNITY; MALE; MICROGLIA; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

RATTUS;

EID: 70949098598     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.01.013     Document Type: Article

References (36)

1. De Jong W.H., and Borm P.J. Drug delivery and nanoparticles: applications and hazards. Int J Nanomed. 3 (2008) 133-149
2. Gu H., Wang S., Messam C.A., and Yao Z. Distribution of nestin immunoreactivity in the normal adult human forebrain. Brain Res. 943 (2002) 174-180
3. Sharma H.S. Nanoneuroscience: emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomedicine. 2 (2007) 753-758
4. Oberdorster G., Oberdorster E., and Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113 (2005) 823-839
5. Akerman M.E., Chan W.C., Laakkonen P., Bhatia S.N., and Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci U S A. 99 (2002) 12617-12621
6. Tetley T.D. Health effects of nanomaterials. Biochem Soc Trans. 35 (2007) 527-531
7. Yamawaki H., and Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ J. 70 (2006) 129-140
8. Cannata-Andia J.B., and Fernandez-Martin J.L. The clinical impact of aluminium overload in renal failure. Nephrol Dial Transplant. 17 Suppl 2 (2002) 9-12
9. Stacchiotti A., Rodella L.F., Ricci F., Rezzani R., Lavazza A., and Bianchi R. Stress proteins expression in rat kidney and liver chronically exposed to aluminium sulphate. Histol Histopathol. 21 (2006) 131-140
10. Fattoretti P., Bertoni-Freddari C., Balietti M., Giorgetti B., Solazzi M., and Zatta P. Chronic aluminum administration to old rats results in increased levels of brain metal ions and enlarged hippocampal mossy fibers. Ann N Y Acad Sci. 1019 (2004) 44-47
11. Fattoretti P., Bertoni-Freddari C., Balietti M., Mocchegiani E., Scancar J., Zambenedetti P., et al. The effect of chronic aluminum(III) administration on the nervous system of aged rats: clues to understand its suggested role in Alzheimer's disease. J Alzheimers Dis. 5 (2003) 437-444
12. McGonigle R.J., and Parsons V. Aluminium-induced anaemia in haemodialysis patients. Nephron. 39 (1985) 1-9
13. Malluche H.H. Aluminium and bone disease in chronic renal failure. Nephrol Dial Transplant. 17 Suppl 2 (2002) 21-24
14. Campbell A., and Bondy S.C. Aluminum induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer's disease. Cell Mol Biol. 46 (2000) 721-730
15. McDermott J.R., Smith A.I., Ward M.K., Parkinson I.S., and Kerr D.N. Brain-aluminium concentration in dialysis encephalopathy. Lancet. 1 (1978) 901-904
16. Larsson B., Karlsson J.E., and Nielsen J. Respiratory and ocular symptoms in workers exposed to potassium aluminium-tetrafluoride soldering flux. Int Arch Occup Environ Health. 80 (2007) 627-633
17. Corain B., Bombi G.G., Tapparo A., Nicolini M., Zatta P., Perazzolo M., et al. Alzheimer's disease and aluminum toxicology. Environ Health Perspect. 89 (1990) 233-235
18. Chen L., Yokel R.A., Hennig B., and Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol. 3 (2008) 286-295
19. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
20. Katafuchi T., Kondo T., Yasaka T., Kubo K., Take S., and Yoshimura M. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue. Neuroscience. 120 (2003) 837-845
21. Ayoub A.E., and Salm A.K. Increased morphological diversity of microglia in the activated hypothalamic supraoptic nucleus. J Neurosci. 23 (2003) 7759-7766
22. Damoiseaux J.G., Dopp E.A., Calame W., Chao D., MacPherson G.G., and Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 83 (1994) 140-147
23. Beiter T., Artelt M.R., Trautmann K., and Schluesener H.J. Experimental autoimmune neuritis induces differential microglia activation in the rat spinal cord. J Neuroimmunol. 160 (2005) 25-31
24. Beschorner R., Nguyen T.D., Gozalan F., Pedal I., Mattern R., Schluesener H.J., et al. CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury. Acta Neuropathol (Berl). 103 (2002) 541-549
25. Seaton A., and Donaldson K. Nanoscience, nanotoxicology, and the need to think small. Lancet. 365 (2005) 923-924
26. Oberdorster G., Ferin J., Gelein R., Soderholm S.C., and Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect. 97 (1992) 193-199
27. Sayes C.M., Reed K.L., and Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 97 (2007) 163-180
28. Giavaresi G., Tschon M., Daly J.H., Liggat J.J., Sutherland D.S., Agheli H., et al. In vitro and in vivo response to nanotopographically-modified surfaces of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and polycaprolactone. J Biomater Sci Polym Ed 17 (2006) 1405-1423
29. Kagan V.E., Bayir H., and Shvedova A.A. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine. 1 (2005) 313-316
30. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2 (2003) 973-985
31. Mertsch K., Hanisch U.K., Kettenmann H., and Schnitzer J. Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J Comp Neurol. 431 (2001) 217-227
32. Krum J.M., and Rosenstein J.M. Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds. Exp Neurol. 160 (1999) 348-360
33. Morshead C.M., Reynolds B.A., Craig C.G., McBurney M.W., Staines W.A., Morassutti D., et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron. 13 (1994) 1071-1082
34. Yao P., Huang J., Kang C.S., Pu P.Y., and Chang J. [Construction of multifunctonal nano-delivery system crossing blood brain barrier]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28 (2006) 481-485
35. 2 nanoparticles. Toxicology. 254 (2008) 82-90
36. Long T.C., Tajuba J., Sama P., Saleh N., Swartz C., Parker J., et al. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect. 115 (2007) 1631-1637